{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:41:36Z","timestamp":1792244496747,"version":"4.4.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ghir.2026.101728","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:43:57Z","timestamp":1791319437000},"page":"101728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Endocrine therapies and hormonal dysfunction after traumatic brain injury: A scoping review"],"prefix":"10.1016","volume":"85","author":[{"given":"Caitlyn","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthi","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.J.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2026.101728_bb0005","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2019","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ghir.2026.101728_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1556147","article-title":"Global, regional, and national burdens of traumatic brain injury from 1990 to 2021","volume":"13","author":"Yan","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ghir.2026.101728_bb0015","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.amepre.2025.01.001","article-title":"Global burden of traumatic brain injury in 204 countries and territories from 1990 to 2021","volume":"68","author":"Zhong","year":"2025","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ghir.2026.101728_bb0020","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.apmr.2010.05.017","article-title":"Position statement: definition of traumatic brain injury","volume":"91","author":"Menon","year":"2010","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.ghir.2026.101728_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness","volume":"304","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2026.101728_bb0030","series-title":"Traumatic Brain Injury: A Roadmap for Accelerating Progress","author":"National Academies of Sciences Engineering and Medicine, Health and mMedicine dDivision, bBoard on hHealth cCare sServices, bBoard on hHealth sSciences pPolicy, cCommittee on aAccelerating Progress in tTraumatic bBrain iInjury rResearch and cCare, aAcute cCare aAfter tTraumatic bBrain iInjury","year":"2022"},{"key":"10.1016\/j.ghir.2026.101728_bb0035","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1089\/neu.2015.4121","article-title":"Adherence to guidelines in adult patients with traumatic brain injury: a living systematic review","volume":"38","author":"Cnossen","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101728_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cells13050385","article-title":"Traumatic brain injury recovery with photobiomodulation: cellular mechanisms, clinical evidence, and future potential","volume":"13","author":"Lim","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ghir.2026.101728_bb0045","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s13311-023-01438-5","article-title":"Pharmacotherapy for traumatic brain injury: the next generation of clinical trials","volume":"20","author":"Diaz-Arrastia","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ghir.2026.101728_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8100389","article-title":"Revisiting traumatic brain injury: from molecular mechanisms to therapeutic interventions","volume":"8","author":"Jarrahi","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.ghir.2026.101728_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bas.2024.102830","article-title":"Acute neuroendocrine changes after traumatic brain injury","volume":"4","author":"Magyar-Sumegi","year":"2024","journal-title":"Brain Spine"},{"key":"10.1016\/j.ghir.2026.101728_bb0060","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s12028-022-01672-3","article-title":"Endocrine dysfunction after traumatic brain injury: an ignored clinical syndrome?","volume":"39","author":"Mahajan","year":"2023","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.ghir.2026.101728_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2026.101728_bb0070","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1080\/00207454.2023.2280450","article-title":"Impact of the severity of brain injury on secondary adrenal insufficiency in traumatic brain injury patients and the influence of HPA axis dysfunction on prognosis","volume":"134","author":"Li","year":"2024","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ghir.2026.101728_bb0075","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1016\/j.wneu.2024.07.186","article-title":"Anterior pituitary dysfunction after traumatic brain injury: a prospective study","volume":"190","author":"Rai","year":"2024","journal-title":"World Neurosurg."},{"key":"10.1016\/j.ghir.2026.101728_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2025.109148","article-title":"Impact of traumatic brain injury severity on anterior pituitary function: a prospective study","volume":"258","author":"Midhunraj","year":"2025","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ghir.2026.101728_bb0085","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10143-024-03088-3","article-title":"Acute and chronic hypopituitarism following traumatic brain injury: a systematic review and meta-analysis","volume":"47","author":"Aljboor","year":"2024","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.ghir.2026.101728_bb0090","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1089\/neu.2015.4127","article-title":"Detection of growth hormone deficiency in adults with chronic traumatic brain injury","volume":"33","author":"Kreber","year":"2016","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101728_bb0095","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1089\/neu.2015.4109","article-title":"Neuroendocrine disturbances one to five or more years after traumatic brain injury and aneurysmal subarachnoid Hemorrhage: data from the German database on hypopituitarism","volume":"33","author":"Krewer","year":"2016","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101728_bb0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/02688697.2015.1109060","article-title":"Incidence of pituitary dysfunction following traumatic brain injury: a prospective study from a regional neurosurgical Centre","volume":"30","author":"Alavi","year":"2016","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.ghir.2026.101728_bb0105","article-title":"Endocrine dysfunction following traumatic brain injury: a 5-year follow-up nationwide-based study","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ghir.2026.101728_bb0110","article-title":"Pituitary dysfunction following mild traumatic brain injury in female athletes: neuropsychological and psychological findings","author":"Eggertsd\u00f3ttir Claessen","year":"2025","journal-title":"NeuroRehabil. Int. Interdiscip. J."},{"key":"10.1016\/j.ghir.2026.101728_bb0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2006.02688.x","article-title":"Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients","volume":"66","author":"Agha","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101728_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133323","article-title":"Growth hormone deficiency following traumatic brain injury","volume":"20","author":"Kgosidialwa","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ghir.2026.101728_bb0125","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1592\/phco.19.18.1432.30891","article-title":"Effect of recombinant human growth hormone and insulin-like growth factor-1 administration on IGF-1 and IGF-binding protein-3 levels in brain injury","volume":"19","author":"Rockich","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ghir.2026.101728_bb0130","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3171\/jns.2006.105.6.843","article-title":"Systemic metabolic effects of combined insulin-like growth factor--I and growth hormone therapy in patients who have sustained acute traumatic brain injury","volume":"105","author":"Hatton","year":"2006","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ghir.2026.101728_bb0135","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1089\/neu.2009.1253","article-title":"Effect of growth hormone replacement therapy on cognition after traumatic brain injury","volume":"27","author":"High","year":"2010","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101728_bb0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/02699052.2010.536196","article-title":"Effects of growth hormone (GH) replacement and cognitive rehabilitation in patients with cognitive disorders after traumatic brain injury","volume":"25","author":"Reimunde","year":"2011","journal-title":"Brain Inj."},{"key":"10.1016\/j.ghir.2026.101728_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00520","article-title":"Phase 2 randomized, placebo-controlled clinical trial of recombinant human growth hormone (rhGH) during rehabilitation from traumatic brain injury","volume":"9","author":"Dubiel","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ghir.2026.101728_bb0150","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1089\/neu.2019.6690","article-title":"Growth hormone alters brain morphometry, connectivity, and behavior in subjects with fatigue after mild traumatic brain injury","volume":"37","author":"Wright","year":"2020","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101728_bb0155","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1089\/neu.2012.2705","article-title":"Growth hormone replacement therapy in patients with traumatic brain injury","volume":"30","author":"Moreau","year":"2013","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101728_bb0160","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/BF03350340","article-title":"Psychiatric and neuropsychological changes in growth hormone-deficient patients after traumatic brain injury in response to growth hormone therapy","volume":"33","author":"Maric","year":"2010","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ghir.2026.101728_bb0165","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ghir.2008.08.007","article-title":"Growth hormone deficient patients after traumatic brain injury -- baseline characteristics and benefits after growth hormone replacement -- an analysis of the German KIMS database","volume":"18","author":"Kreitschmann-Andermahr","year":"2008","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2026.101728_bb0170","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jpeds.2007.12.046","article-title":"Traumatic brain injury is a rarely reported cause of growth hormone deficiency","volume":"152","author":"McDonald","year":"2008","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2026.101728_bb0175","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yhbeh.2012.02.022","article-title":"Growth hormone (GH) and brain trauma","volume":"63","author":"Devesa","year":"2013","journal-title":"Horm. Behav."},{"key":"10.1016\/j.ghir.2026.101728_bb0180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EJE-14-0654","article-title":"GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database","volume":"172","author":"Gardner","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101728_bb0185","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/neu.2016.4552","article-title":"Functional changes after recombinant human growth hormone replacement in patients with chronic traumatic brain injury and abnormal growth hormone secretion","volume":"34","author":"Mossberg","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101728_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-87385-7","article-title":"Growth hormone deficiency testing and treatment following mild traumatic brain injury","volume":"11","author":"Mercier","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ghir.2026.101728_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ghir.2023.101544","article-title":"Metabolic and quality of life effects of growth hormone replacement in patients with TBI and AGHD: a pilot study","volume":"71","author":"Herodes","year":"2023","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2026.101728_bb0200","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1089\/neu.2017.5374","article-title":"Central infusion of insulin-like growth Factor-1 increases hippocampal neurogenesis and improves neurobehavioral function after traumatic brain injury","volume":"35","author":"Carlson","year":"2018","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101728_bb0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.intimp.2016.01.015","article-title":"What are the progesterone-induced changes of the outcome and the serum markers of injury, oxidant activity and inflammation in diffuse axonal injury patients?","volume":"32","author":"Mofid","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ghir.2026.101728_bb0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/02699052.2016.1213421","article-title":"Does progesterone improve outcome in diffuse axonal injury?","volume":"31","author":"Soltani","year":"2017","journal-title":"Brain Inj."},{"key":"10.1016\/j.ghir.2026.101728_bb0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/neu.2015.4313","article-title":"Very early Administration of Progesterone Does not Improve Neuropsychological Outcomes in subjects with moderate to severe traumatic brain injury","volume":"34","author":"Goldstein","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101728_bb0220","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/cc6887","article-title":"Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial","volume":"12","author":"Xiao","year":"2008","journal-title":"Crit. Care"},{"key":"10.1016\/j.ghir.2026.101728_bb0225","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/2277-9175.100176","article-title":"Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: a randomized clinical trial with placebo group","volume":"1","author":"Aminmansour","year":"2012","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.ghir.2026.101728_bb0230","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.clineuro.2013.06.013","article-title":"Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma","volume":"115","author":"Shakeri","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ghir.2026.101728_bb0235","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1411090","article-title":"A clinical trial of progesterone for severe traumatic brain injury","volume":"371","author":"Skolnick","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2026.101728_bb0240","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/roaic.roaic_106_16","article-title":"Impact of progesterone administration on outcome in patients with severe traumatic brain injury","volume":"4","author":"Aboukhabar","year":"2017","journal-title":"Res. Opin. Anaesth. Intensive Care"},{"key":"10.1016\/j.ghir.2026.101728_bb0245","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.annemergmed.2006.07.932","article-title":"ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury","volume":"49","author":"Wright","year":"2007","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.ghir.2026.101728_bb0250","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa1404304","article-title":"Very early administration of progesterone for acute traumatic brain injury","volume":"371","author":"Wright","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2026.101728_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010011","article-title":"The role of estradiol in traumatic brain injury: mechanism and treatment potential","volume":"22","author":"K\u00f6vesdi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ghir.2026.101728_bb0260","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.410120412","article-title":"A placebo-controlled trial shows no effect of vasopressin on recovery from closed head injury","volume":"12","author":"Reichert","year":"1982","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ghir.2026.101728_bb0265","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1212\/WNL.43.1_Part_1.103","article-title":"A controlled trial with vasopressin analogue (DGAVP) on cognitive recovery immediately after head trauma","volume":"43","author":"Bohnen","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.ghir.2026.101728_bb0270","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/TA.0b013e3182a99d48","article-title":"Vasopressin for cerebral perfusion pressure management in patients with severe traumatic brain injury","volume":"75","author":"Van Haren","year":"2013","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.ghir.2026.101728_bb0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/000313481808400121","article-title":"*Does vasopressin exacerbate cerebral edema in patients with severe traumatic brain injury?*","volume":"84","author":"Allen","year":"2018","journal-title":"Am. Surg."},{"key":"10.1016\/j.ghir.2026.101728_bb0280","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12028-010-9448-9","article-title":"Vasopressor use and effect on blood pressure after severe adult traumatic brain injury","volume":"15","author":"Sookplung","year":"2011","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.ghir.2026.101728_bb0285","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/TA.0000000000002521","article-title":"Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury","volume":"88","author":"Furay","year":"2020","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.ghir.2026.101728_bb0290","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12028-019-00899-x","article-title":"The role of desmopressin on hematoma expansion in patients with mild traumatic brain injury prescribed pre-injury antiplatelet medications","volume":"33","author":"Barletta","year":"2020","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.ghir.2026.101728_bb0295","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.amjsurg.2021.07.050","article-title":"Platelet dysfunction in patients with traumatic intracranial hemorrhage: do desmopressin and platelet therapy help or harm?","volume":"223","author":"Glass","year":"2022","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.ghir.2026.101728_bb0300","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1007\/s10072-024-07379-x","article-title":"A multicenter study of DDAVP versus platelet transfusions for antiplatelet agent reversal in patients with traumatic brain injury","volume":"45","author":"Westfall","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ghir.2026.101728_bb0305","doi-asserted-by":"crossref","DOI":"10.1007\/BF00257471","article-title":"Dexamethasone therapy and endogenous cortisol production in severe pediatric head injury","volume":"14","author":"Fanconi","year":"1988","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ghir.2026.101728_bb0310","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(04)17188-2","article-title":"Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial","volume":"364","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2026.101728_bb0315","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(05)66552-X","article-title":"Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury\u2014outcomes at 6 months","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2026.101728_bb0320","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.surneu.2006.11.052","article-title":"Hyponatremia in patients with traumatic brain injury: incidence, mechanism, and response to sodium supplementation or retention therapy with hydrocortisone","volume":"68","author":"Moro","year":"2007","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.ghir.2026.101728_bb0325","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.wneu.2017.09.013","article-title":"Hyponatremia in traumatic brain injury: a practical management protocol","volume":"108","author":"Rajagopal","year":"2017","journal-title":"World Neurosurg."},{"key":"10.1016\/j.ghir.2026.101728_bb0330","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1385\/NCC:5:3:176","article-title":"Hemodynamic steroid responsiveness is predictive of neurological outcome after traumatic brain injury","volume":"5","author":"Bernard","year":"2006","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.ghir.2026.101728_bb0335","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S2213-2600(14)70144-4","article-title":"Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial","volume":"2","author":"Asehnoune","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ghir.2026.101728_bb0340","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/10903127.2023.2187905","article-title":"Prehospital guidelines for the Management of Traumatic Brain Injury -- 3rd edition","volume":"27","author":"Lulla","year":"2023","journal-title":"Prehosp. Emerg. Care"},{"key":"10.1016\/j.ghir.2026.101728_bb0345","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.3390\/ijms18112441","article-title":"Neurotrophic and Neuroregenerative effects of GH\/IGF1","volume":"18","author":"Bianchi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ghir.2026.101728_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00052","article-title":"IGF-I: a key growth factor that regulates neurogenesis and synaptogenesis from embryonic to adult stages of the brain","volume":"10","author":"Nieto-Est\u00e9vez","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ghir.2026.101728_bb0355","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1152\/physiol.00009.2025","article-title":"Growth hormone and IGF-1 actions in the brain and neuropsychiatric diseases","volume":"41","author":"Aguiar-Oliveira","year":"2026","journal-title":"Physiology"},{"key":"10.1016\/j.ghir.2026.101728_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/736104","article-title":"Role and importance of IGF-1 in traumatic brain injuries","volume":"2015","author":"Mangiola","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ghir.2026.101728_bb0365","article-title":"Influence of traumatic brain injury on serum levels of pituitary, thyroid, adrenal and gonadal hormones","volume":"104","author":"Zhang","year":"2025","journal-title":"Medicine"},{"key":"10.1016\/j.ghir.2026.101728_bb0370","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/er.2014-1065","article-title":"Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach","volume":"36","author":"Tanriverdi","year":"2015","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2026.101728_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1456195","article-title":"Growth hormone\/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulin","volume":"15","author":"Yuen","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ghir.2026.101728_bb0380","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-25235-6","article-title":"Normative data for insulin-like growth factor-1 and insulin-like growth factor binding protein-3 and their determinants in healthy adult males from India: the INDIIGo study","volume":"15","author":"Shah","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ghir.2026.101728_bb0385","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1530\/EC-21-0175","article-title":"Reference values for IGF-I serum concentration in an adult population: use of the VARIETE cohort for two new immunoassays","volume":"10","author":"Sabbah","year":"2021","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.ghir.2026.101728_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185561","article-title":"Reference ranges for serum insulin-like growth factor I (IGF-I) in healthy Chinese adults","volume":"12","author":"Zhu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ghir.2026.101728_bb0395","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1210\/jc.2016-1257","article-title":"Reference values for IGF-I serum concentrations: comparison of six immunoassays","volume":"101","author":"Chanson","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101728_bb0400","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101728_bb0405","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainres.2004.02.049","article-title":"Different levels of neuroprotection by two insulin-like growth factor-I splice variants","volume":"1009","author":"Aperghis","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ghir.2026.101728_bb0410","article-title":"The effect and mechanism of growth hormone replacement on cognitive function in rats with traumatic brain injury","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ghir.2026.101728_bb0415","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.672392","article-title":"Early IGF-1 gene therapy prevented oxidative stress and cognitive deficits induced by traumatic brain injury","volume":"12","author":"Montivero","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ghir.2026.101728_bb0420","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-025-01998-x","article-title":"Systemic IGF-1 administration prevents traumatic brain injury induced gut permeability, dysmorphia, dysbiosis, and the increased number of immature dentate granule cells","volume":"13","author":"Venkatasamy","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ghir.2026.101728_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2025.102015","article-title":"Outcomes of recombinant growth hormone therapy in the traumatic brain injury population: a scoping review","volume":"39","author":"Batson","year":"2025","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101728_bb0430","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.suc.2017.06.003","article-title":"Acute Management of Traumatic Brain Injury","volume":"97","author":"Vella","year":"2017","journal-title":"Surg. Clin. N. Am."},{"key":"10.1016\/j.ghir.2026.101728_bb0435","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/jnnp-2016-315500","article-title":"The screening and management of pituitary dysfunction following traumatic brain injury in adults: British neurotrauma group guidance","volume":"88","author":"Tan","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ghir.2026.101728_bb0440","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/02688697.2019.1699902","article-title":"A national survey of clinical practice of surveillance for post-traumatic brain injury hypopituitarism in the United Kingdom and Ireland","volume":"34","author":"Emelifeonwu","year":"2020","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.ghir.2026.101728_bb0445","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/archdischild-2016-311609","article-title":"Pituitary dysfunction after traumatic brain injury: are there definitive data in children?","volume":"102","author":"Casano-Sancho","year":"2017","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ghir.2026.101728_bb0450","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12020-013-0049-1","article-title":"Traumatic brain injury: endocrine consequences in children and adults","volume":"45","author":"Richmond","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.ghir.2026.101728_bb0455","series-title":"Evidence-Based Review of Moderate to Severe Acquired Brain Injury","article-title":"Neuroendocrine Function and Disorders after Acquired Brain Injury","author":"Bateman","year":"2019"},{"key":"10.1016\/j.ghir.2026.101728_bb0460","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12909-024-05027-8","article-title":"Coverage of education and training of traumatic brain injury-induced growth hormone deficiency in US residency and fellowship programs: a cross-sectional study","volume":"24","author":"C\u00e1rdenas","year":"2024","journal-title":"BMC Med. Educ."},{"key":"10.1016\/j.ghir.2026.101728_bb0465","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40120-023-00553-x","article-title":"Recognition and practice of hypopituitarism after traumatic brain injury and subarachnoid Hemorrhage in Japan: a survey","volume":"13","author":"Tahara","year":"2024","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.ghir.2026.101728_bb0470","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12974-024-03156-x","article-title":"The potential of gene delivery for the treatment of traumatic brain injury","volume":"21","author":"Dooley","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ghir.2026.101728_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12050527","article-title":"Current clinical trials in traumatic brain injury","volume":"12","author":"Ahmed","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.ghir.2026.101728_bb0480","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3171\/2012.12.JNS121084","article-title":"Effect of rosuvastatin on cytokines after traumatic head injury","volume":"118","author":"S\u00e1nchez-Aguilar","year":"2013","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ghir.2026.101728_bb0485","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/jamasurg.2023.3848","article-title":"Tranexamic acid, mortality, and intracranial hemorrhage type in moderate or severe traumatic brain injury","volume":"158","author":"McKinley","year":"2023","journal-title":"JAMA Surg."},{"issue":"6","key":"10.1016\/j.ghir.2026.101728_bb0490","doi-asserted-by":"crossref","first-page":"e1695","DOI":"10.1210\/clinem\/dgag090","article-title":"Approach to the patient with traumatic brain injury-induced pituitary dysfunction","volume":"111","author":"Kelestimur","year":"2026","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101728_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415699","article-title":"The role of apoptosis and autophagy in the hypothalamic-pituitary-adrenal (HPA) axis after traumatic brain injury (TBI)","volume":"23","author":"Taheri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ghir.2026.101728_bb0500","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s11154-023-09847-9","article-title":"Hypoprolactinemia. Does it matter","volume":"25","author":"Karaca","year":"2024","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ghir.2026.101728_bb0505","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s11154-024-09904-x","article-title":"Traumatic brain injury and prolactin","volume":"25","author":"Hacioglu","year":"2024","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ghir.2026.101728_bb0510","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1089\/neu.2013.3212","article-title":"Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study","volume":"31","author":"Kelly","year":"2014","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ghir.2026.101728_bb0515","article-title":"Boxing as a sport activity associated with isolated GH deficiency","volume":"27","author":"Kelestimur","year":"2004","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ghir.2026.101728_bb0520","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2265.2006.02737.x","article-title":"Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism","volume":"66","author":"Tanriverdi","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101728_bb0525","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2012.00011","article-title":"High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury","volume":"3","author":"Wilkinson","year":"2012","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ghir.2026.101728_bb0530","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663742600050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663742600050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:53:13Z","timestamp":1792241593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109663742600050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":106,"alternative-id":["S109663742600050X"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101728","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine therapies and hormonal dysfunction after traumatic brain injury: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101728"}}